Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pregnancy Disorders

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 137 articles:
HTML format



Single Articles


    December 2021
  1. FLEISHMAN R
    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    PubMed    


    July 2021
  2. PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
    Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2021;398:41-52.
    PubMed     Abstract available


  3. ISBEIH M, Venkateswaran M, Abbas E, Abu-Khader K, et al
    Gestational age recorded at delivery versus estimations using antenatal care data from the Electronic Maternal and Child Health Registry in the West Bank: a comparative analysis.
    Lancet. 2021;398 Suppl 1:S31.
    PubMed     Abstract available


  4. EL-QATRAWI KJ
    Effect of hypertension on pregnancy outcomes at UNRWA health centres in Gaza governorates: a comparative study.
    Lancet. 2021;398 Suppl 1:S26.
    PubMed     Abstract available


  5. BOGALE B, Morkrid K, O'Donnell B, Ghanem B, et al
    Development of a targeted client communication intervention for pregnant and post-partum women: a descriptive study.
    Lancet. 2021;398 Suppl 1:S18.
    PubMed     Abstract available


    May 2021
  6. CHAPPELL LC, Cluver CA, Kingdom J, Tong S, et al
    Pre-eclampsia.
    Lancet. 2021 May 27. pii: S0140-6736(20)32335.
    PubMed     Abstract available


    April 2021
  7. THE LANCET
    Miscarriage: worldwide reform of care is needed.
    Lancet. 2021 Apr 26. pii: S0140-6736(21)00954.
    PubMed    


  8. COOMARASAMY A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, et al
    Recurrent miscarriage: evidence to accelerate action.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00681.
    PubMed     Abstract available


  9. COOMARASAMY A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, et al
    Sporadic miscarriage: evidence to provide effective care.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00683.
    PubMed     Abstract available


  10. QUENBY S, Gallos ID, Dhillon-Smith RK, Podesek M, et al
    Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00682.
    PubMed     Abstract available


  11. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    PubMed    


  12. LOCKMAN S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAA
    Lancet. 2021;397:1276-1292.
    PubMed     Abstract available


  13. GILLEECE Y, Krankowska D
    ART in pregnant women living with HIV.
    Lancet. 2021;397:1240-1241.
    PubMed    


    January 2021
  14. BARDAJI A, Sevene E, Cutland C, Menendez C, et al
    The need for a global COVID-19 maternal immunisation research plan.
    Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
    PubMed    


    November 2020
  15. CHAN JCN, Lim LL, Wareham NJ, Shaw JE, et al
    The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32374.
    PubMed    


    September 2020
  16. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    PubMed    


  17. SHAHAR-NISSAN K, Pardo J, Peled O, Krause I, et al
    Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;396:779-785.
    PubMed     Abstract available


  18. LEVY L, Meuwly JY, Sarivalasis A, Achtari C, et al
    Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
    Lancet. 2020;396:725.
    PubMed    


  19. EVANS DK, Acosta AM
    Lifting bans on pregnant girls in school.
    Lancet. 2020;396:667-668.
    PubMed    


    August 2020
  20. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    PubMed    


  21. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    PubMed     Abstract available


  22. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    PubMed    


  23. VON DADELSZEN P, Bhutta ZA, Sharma S, Bone J, et al
    The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis.
    Lancet. 2020;396:553-563.
    PubMed     Abstract available


  24. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    PubMed    


  25. MAEDA Y, Ogawa K, Kamihara Y, Tanimoto T, et al
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:308.
    PubMed    


  26. CHAPPELL LC, Juszczak E, Shennan A
    Managing late preterm pre-eclampsia - Authors' reply.
    Lancet. 2020;396:308-309.
    PubMed    


  27. CARBILLON L
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:307-308.
    PubMed    


    July 2020
  28. CLUVER CA, Herbst P, Griffith-Richards S, Hassan M, et al
    Coarctation of the aorta: a rare cause of severe hypertension in pregnancy.
    Lancet. 2020;396:62.
    PubMed    


    May 2020
  29. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    PubMed    


    April 2020
  30. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    PubMed    


    March 2020
  31. MEMISH ZA, Perlman S, Van Kerkhove MD, Zumla A, et al
    Middle East respiratory syndrome.
    Lancet. 2020;395:1063-1077.
    PubMed     Abstract available


  32. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    PubMed     Abstract available


  33. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    PubMed    


  34. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    


  35. FORD J
    Ursodeoxycholic acid for adverse perinatal outcomes.
    Lancet. 2020;395:780.
    PubMed    


    February 2020
  36. THE LANCET
    Appropriate care for pregnant women in Ebola outbreaks.
    Lancet. 2020;395:468.
    PubMed    


  37. THE LANCET
    Preventing teenage pregnancies in Brazil.
    Lancet. 2020;395:468.
    PubMed    


  38. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    PubMed    


  39. UZOIGWE CE
    No global consensus among doctors or society on abortion.
    Lancet. 2020;395:e17.
    PubMed    


  40. DUHIG K, Myers J, Seed PT, Shennan AH, et al
    Placental growth factor testing in suspected pre-eclampsia - Authors' reply.
    Lancet. 2020;395:336-337.
    PubMed    


  41. KERMACK AJ, Stocker LJ, Coleman M
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335-336.
    PubMed    


  42. TANNER M, Mol BW
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335.
    PubMed    


    January 2020
  43. HOFFMAN MK, Goudar SS, Kodkany BS, Metgud M, et al
    Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:285-293.
    PubMed     Abstract available


  44. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    


  45. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    


  46. QUINLIVAN JA
    Simple and safe: preventing preterm birth with aspirin.
    Lancet. 2020;395:250-252.
    PubMed    


  47. AIGA H
    Adapting workforce density threshold to WHO's new antenatal care recommendations.
    Lancet. 2020;395:27.
    PubMed    


    November 2019
  48. LYERLY AD
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    PubMed    


  49. CERDEIRA AS, Tome M, Moore N, Lim L, et al
    Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.
    Lancet. 2019;394:e37.
    PubMed    


    October 2019
  50. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    PubMed    


    August 2019
  51. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    PubMed     Abstract available


  52. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    PubMed    


  53. LAWRIE TA
    Prepregnancy calcium supplementation and pre-eclampsia - Author's reply.
    Lancet. 2019;394:e8.
    PubMed    


  54. MAEDA Y, Suzuki Y, Yamamoto K, Tanimoto T, et al
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e7.
    PubMed    


  55. PONZETTO A, Figura N, Riva P
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e6.
    PubMed    


  56. HAIGH A, Haigh K
    Coroners' investigations of stillbirths.
    Lancet. 2019;394:564.
    PubMed    


  57. KROUSHEV A, Rolnik DL, Mol BW
    Zhang's guidelines vs WHO guidelines for diagnosing labour dystocia.
    Lancet. 2019;394:e9.
    PubMed    


  58. SHIMAZAKI M, Maeda Y, Ogawa K, Tanimoto T, et al
    Zhang's guidelines vs WHO guidelines for diagnosing labour dystocia.
    Lancet. 2019;394:e10.
    PubMed    


  59. BERNITZ S, Dalbye R, Olsen IC, Blix E, et al
    Zhang's guidelines vs WHO guidelines for diagnosing labour dystocia - Authors' reply.
    Lancet. 2019;394:e11.
    PubMed    


  60. DANDONA R, Kumar GA
    Enhancing the National Family Health Survey-5 for policy making.
    Lancet. 2019;394:563-564.
    PubMed    


  61. TANG GY, Parekh J
    Brexanolone injection for post-partum depression treatment.
    Lancet. 2019;394:379.
    PubMed    


  62. MELTZER-BRODY S, Colquhoun H, Doherty J, Rubinow DR, et al
    Brexanolone injection for post-partum depression treatment - Authors' reply.
    Lancet. 2019;394:380.
    PubMed    


  63. TUFTS JA
    Brexanolone injection for post-partum depression treatment.
    Lancet. 2019;394:379.
    PubMed    


  64. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    PubMed    


  65. CHAPPELL LC, Bell JL, Smith A, Linsell L, et al
    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31270.
    PubMed     Abstract available


  66. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    PubMed     Abstract available


  67. MARSCHALL HU
    Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31607.
    PubMed    


    July 2019
  68. HEMIDA R, van Doorn HC
    Avoid making a mountain out of an invasive hydatidiform mole: do a pregnancy test!
    Lancet. 2019;394:e2.
    PubMed    


  69. HASSAN SS, Gomez-Lopez N
    Reducing maternal mortality: can elabela help in this fight?
    Lancet. 2019;394:8-9.
    PubMed    


  70. PRATILAS GC, Sotiriadis A, Dinas K
    Is high use of caesarean section sometimes justified?
    Lancet. 2019;394:25-26.
    PubMed    


  71. VIVANTI AJ, Voican C, De Luca D, Benachi A, et al
    Intrahepatic cholestasis: suggested future investigations.
    Lancet. 2019 Jul 1. pii: S0140-6736(19)31391.
    PubMed    


  72. OVADIA C, Chappell LC, Williamson C
    Intrahepatic cholestasis: suggested future investigations - Authors' reply.
    Lancet. 2019 Jul 1. pii: S0140-6736(19)31389.
    PubMed    


    June 2019
  73. SMIT JG
    Ongoing pregnancy as the primary outcome for the inSIGHT study.
    Lancet. 2019;393:2389.
    PubMed    


  74. KNIGHT M, Chiocchia V, Partlett C, Rivero-Arias O, et al
    Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.
    Lancet. 2019;393:2395-2403.
    PubMed     Abstract available


  75. STEPHENSON J, Vogel C, Hall J, Hutchinson J, et al
    Preconception health in England: a proposal for annual reporting with core metrics.
    Lancet. 2019;393:2262-2271.
    PubMed     Abstract available


    May 2019
  76. THE LANCET
    Centring the invisible mother.
    Lancet. 2019;393:2010.
    PubMed    


  77. MATTHEWS T, Hayes B
    Preventable brain injury in term labour.
    Lancet. 2019;393:1805.
    PubMed    


  78. BUJOLD E, Chaillet N, Kingdom J
    Placental growth factor testing for suspected pre-eclampsia.
    Lancet. 2019;393:1775-1776.
    PubMed    


  79. SMIT EF, de Langen AJ
    Pembrolizumab for all PD-L1-positive NSCLC.
    Lancet. 2019;393:1776-1778.
    PubMed    


    April 2019
  80. THE LANCET
    Progress on investigating stillbirths.
    Lancet. 2019;393:1386.
    PubMed    


  81. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    PubMed     Abstract available


    March 2019
  82. THE LANCET
    Gestational diabetes in England: cause for concern.
    Lancet. 2019;393:1262.
    PubMed    


  83. WEI D, Liu JY, Sun Y, Shi Y, et al
    Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
    Lancet. 2019;393:1310-1318.
    PubMed     Abstract available


  84. SOBHY S, Arroyo-Manzano D, Murugesu N, Karthikeyan G, et al
    Maternal and perinatal mortality and complications associated with caesarean section in low-income and middle-income countries: a systematic review and meta-analysis.
    Lancet. 2019 Mar 28. pii: S0140-6736(18)32386.
    PubMed     Abstract available


  85. LARSSON C, Hedberg CL, Lundgren E, Soderstrom L, et al
    Anal incontinence after caesarean and vaginal delivery in Sweden: a national population-based study.
    Lancet. 2019;393:1233-1239.
    PubMed     Abstract available


  86. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    PubMed    


  87. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    PubMed     Abstract available


    February 2019
  88. KLEBANOFF MA
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    PubMed    


  89. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    PubMed     Abstract available


  90. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    PubMed    


  91. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    PubMed    


  92. UZOIGWE CE
    Abortion in Argentina.
    Lancet. 2019;393:744-745.
    PubMed    


  93. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    PubMed     Abstract available


  94. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    PubMed    


    January 2019
  95. LORD J, McMullan DJ, Eberhardt RY, Rinck G, et al
    Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
    Lancet. 2019 Jan 31. pii: S0140-6736(18)31940.
    PubMed     Abstract available


  96. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
    Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2019;393:330-339.
    PubMed     Abstract available


  97. BUJOLD E, Hyett J
    Calcium supplementation for prevention of pre-eclampsia.
    Lancet. 2019;393:298-300.
    PubMed    


  98. GOISIS A, Remes H, Martikainen P, Klemetti R, et al
    Medically assisted reproduction and birth outcomes: a within-family analysis using Finnish population registers.
    Lancet. 2019 Jan 14. pii: S0140-6736(18)31863.
    PubMed     Abstract available


    December 2018
  99. DEVI S
    FRONTLINE: a new treatment facility for Ebola virus disease.
    Lancet. 2018;392:2428.
    PubMed    


    November 2018
  100. THE LANCET
    Addressing preventable stillbirth and brain injury.
    Lancet. 2018;392:2238.
    PubMed    


  101. WALKER KF, Thornton JG
    Encouraging awareness of fetal movements is harmful.
    Lancet. 2018;392:1601-1602.
    PubMed    


  102. NORMAN JE, Heazell AEP, Rodriguez A, Weir CJ, et al
    Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial.
    Lancet. 2018;392:1629-1638.
    PubMed     Abstract available


    October 2018
  103. BETRAN AP, Temmerman M, Kingdon C, Mohiddin A, et al
    Interventions to reduce unnecessary caesarean sections in healthy women and babies.
    Lancet. 2018;392:1358-1368.
    PubMed     Abstract available


  104. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Abstract available


  105. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed    


    September 2018
  106. TEMMERMAN M, Lawn JE
    Stillbirths count, but it is now time to count them all.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
    PubMed    


  107. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
    Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
    PubMed     Abstract available


  108. MELTZER-BRODY S, Colquhoun H, Riesenberg R, Epperson CN, et al
    Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
    Lancet. 2018;392:1058-1070.
    PubMed     Abstract available


  109. THE LANCET
    Mismanaged expectations-maternal morbidity in the USA.
    Lancet. 2018;392:892.
    PubMed    


    August 2018
  110. GRESSLER LE, Titus-Glover D, Shaya FT
    Treatment modalities for pregnant women with opioid use disorder.
    Lancet. 2018;392:551.
    PubMed    


  111. THE LANCET
    Zika-associated health and development problems in children.
    Lancet. 2018;392:532.
    PubMed    


  112. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed    


    July 2018
  113. HARRISON N, Hewitt H, Pandya P, Reisel D, et al
    How Montgomery is reconfiguring consent in the UK.
    Lancet. 2018;392:102-104.
    PubMed    


    June 2018
  114. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed    


    May 2018
  115. FLEMING TP, Watkins AJ, Velazquez MA, Mathers JC, et al
    Origins of lifetime health around the time of conception: causes and consequences.
    Lancet. 2018;391:1842-1852.
    PubMed     Abstract available


    April 2018
  116. STEPHENSON J, Heslehurst N, Hall J, Schoenaker DAJM, et al
    Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health.
    Lancet. 2018 Apr 16. pii: S0140-6736(18)30311.
    PubMed     Abstract available


    February 2018
  117. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
    Management of pregnancy loss in the first trimester: a retrospective audit.
    Lancet. 2018;391 Suppl 2:S34.
    PubMed     Abstract available


  118. KATEEB E, Momany E
    Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S11.
    PubMed     Abstract available


  119. CHALMERS I
    Deaths of children and women in Gaza hostilities.
    Lancet. 2018;391:539-540.
    PubMed    


  120. RUBIN L, Belmaker I, Somekh E, Rudolf M, et al
    Deaths of children and women in Gaza hostilities - Authors' reply.
    Lancet. 2018;391:540.
    PubMed    


    January 2018
  121. GAYET-AGERON A, Prieto-Merino D, Ker K, Shakur H, et al
    Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
    Lancet. 2018;391:125-132.
    PubMed     Abstract available


    November 2017
  122. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    PubMed    


  123. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    PubMed    


    September 2017
  124. GEMZELL-DANIELSSON K, Cleeve A
    Estimating abortion safety: advancements and challenges.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
    PubMed    



  125. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1151-1210.
    PubMed     Abstract available



  126. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1084-1150.
    PubMed     Abstract available


  127. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    PubMed    


  128. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    PubMed     Abstract available


    July 2017
  129. WARE RE, de Montalembert M, Tshilolo L, Abboud MR, et al
    Sickle cell disease.
    Lancet. 2017;390:311-323.
    PubMed     Abstract available


    June 2017
  130. MUNDLE S, Bracken H, Khedikar V, Mulik J, et al
    Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31367.
    PubMed     Abstract available


  131. RODRIGUES LC, Paixao ES
    Risk of Zika-related microcephaly: stable or variable?
    Lancet. 2017 Jun 21. pii: S0140-6736(17)31478.
    PubMed    


  132. DE OLIVEIRA WK, de Franca GVA, Carmo EH, Duncan BB, et al
    Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis.
    Lancet. 2017 Jun 21. pii: S0140-6736(17)31368.
    PubMed     Abstract available


    April 2017
  133. SHANE AL, Sanchez PJ, Stoll BJ
    Neonatal sepsis.
    Lancet. 2017 Apr 20. pii: S0140-6736(17)31002.
    PubMed     Abstract available


  134. BURGESS C, Gasse F, Steinglass R, Yakubu A, et al
    Eliminating maternal and neonatal tetanus and closing the immunity gap.
    Lancet. 2017;389:1380-1381.
    PubMed    


    February 2017
  135. WEBB SA, Litton E
    Prevention is better than cure, but both require high quality evidence.
    Lancet. 2017;389:572.
    PubMed    


  136. THONGNOI P, Praphasiri P, Dawood FS, Lindblade KA, et al
    Maternal death from influenza in tropical Thailand.
    Lancet. 2017;389:571-572.
    PubMed    


    December 2016
  137. GRIFFITHS PD, Bradburn M, Campbell MJ, Cooper CL, et al
    Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study.
    Lancet. 2016 Dec 14. pii: S0140-6736(16)31723.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pregnancy Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: